Expression of Human CD45 Antigen in NOD/SCID Recipients of AML Cells Sorted for Coexpression of CD34, HLA-DR, and CD71
| Patient No. . | Phenotype . | % Nucleated Cells . | No. Cells Injected . | % CD45+ BM . | FISH Analysis on Colonies . | ||
|---|---|---|---|---|---|---|---|
| Positive . | Undetermined . | Negative . | |||||
| 4 | Unsorted | 106 | 16 | ||||
| Unsorted | 5 × 105 | 41 | 3/5 | 2/5 | |||
| CD34+/CD71+/DR+ | 21.95 | NA | |||||
| CD34+/CD71+/DR− | 4.36 | 104 | 0 | ||||
| CD34+/CD71−/DR+ | 1.14 | 4 × 104 | 0 | ||||
| 9 × 103 | 0 | ||||||
| CD34+/CD71−/DR− | 0.56 | 5 × 103 | 39 | 1/4 | 3/4 | ||
| 500 | 0 | ||||||
| CD34− | 71.99 | ≤106 | 0 | ||||
| 8 | Unsorted | 106 | 97 | 5/5 | |||
| CD34+/DR+ | 0.1 | 8 × 103 | 0 | ||||
| 5 × 103 | 0 | ||||||
| CD34+/DR− | 0.01 | 3 × 103 | 18 | 5/5 | |||
| CD34+/CD71+/DR+ | 0.06 | NA | |||||
| CD34+/CD71+/DR− | 0.008 | NA | |||||
| CD34+/CD71−/DR+ | 0.04 | 5 × 103 | 0 | ||||
| CD34+/CD71−/DR− | 0.002 | 2272 | 32 | 5/5 | |||
| 400 | 4 | 3/3 | |||||
| CD34− | 99.89 | 106 | 98 | 4/4 | |||
| 105 | 29 | 4/4 | |||||
| 9 | Unsorted | 106 | 0.2 | ||||
| CD34+/DR+ | 4.6 | 7 × 104 | 0 | ||||
| CD34+/DR− | 4.5 | 105 | 0 | ||||
| 8 × 104 | 0 | ||||||
| 7 × 104 | 0 | ||||||
| CD34+/CD71+/DR+ | 3.7 | NA | |||||
| CD34+/CD71+/DR− | 2.9 | NA | |||||
| CD34+/CD71−/DR+ | 0.9 | 8 × 104 | 0 | ||||
| 4 × 104 | 0 | ||||||
| CD34+/CD71−/DR− | 1.6 | 3.7 × 104 | 1 | ||||
| CD34− | 90.9 | ≤106 | 0 | ||||
| 13 | Unsorted | 106 | 0.1 | ||||
| CD34+/DR+ | 10.3 | 5 × 105 | 0 | ||||
| 3.5 × 105 | 0 | ||||||
| CD34+/DR− | 0.07 | 5 × 105 | 4 | 3/3 | |||
| 105 | 0 | ||||||
| CD34+/CD71+/DR+ | 9.6 | NA | |||||
| CD34+/CD71+/DR− | 0.05 | NA | |||||
| CD34+/CD71−/DR+ | 0.7 | 2.5 × 104 | 0 | ||||
| CD34+/CD71−/DR− | 0.02 | 105 | 13 | 3/3 | |||
| 2 × 104 | 3 | 3/3 | |||||
| CD34− | 89.63 | 5 × 106 | 0 | ||||
| 15 | Unsorted | 106 | 36 | ||||
| CD34+/DR+ | 0.11 | 1.7 × 104 | 0 | ||||
| CD34+/DR− | 0.09 | 5.6 × 103 | 29 | ||||
| CD34+/CD71+/DR+ | 0.02 | NA | |||||
| CD34+/CD71+/DR− | 0.01 | NA | |||||
| CD34+/CD71−/DR+ | 0.09 | 5 × 103 | 0 | ||||
| CD34+/CD71−/DR− | 0.08 | 3.7 × 103 | 40 | ||||
| 2.5 × 103 | 19 | ||||||
| CD34− | 99.8 | 106 | 0 | ||||
| 17 | Unsorted | 106 | 13 | ||||
| 5 × 105 | 11 | ||||||
| 105 | 8 | ||||||
| CD34+/DR+ | 1.3 | 2 × 105 | 0 | ||||
| CD34+/DR− | 5.3 | 3 × 105 | 38 | ||||
| CD34− | 93.4 | 106 | 0 | ||||
| 6 × 105 | 0 | ||||||
| Patient No. . | Phenotype . | % Nucleated Cells . | No. Cells Injected . | % CD45+ BM . | FISH Analysis on Colonies . | ||
|---|---|---|---|---|---|---|---|
| Positive . | Undetermined . | Negative . | |||||
| 4 | Unsorted | 106 | 16 | ||||
| Unsorted | 5 × 105 | 41 | 3/5 | 2/5 | |||
| CD34+/CD71+/DR+ | 21.95 | NA | |||||
| CD34+/CD71+/DR− | 4.36 | 104 | 0 | ||||
| CD34+/CD71−/DR+ | 1.14 | 4 × 104 | 0 | ||||
| 9 × 103 | 0 | ||||||
| CD34+/CD71−/DR− | 0.56 | 5 × 103 | 39 | 1/4 | 3/4 | ||
| 500 | 0 | ||||||
| CD34− | 71.99 | ≤106 | 0 | ||||
| 8 | Unsorted | 106 | 97 | 5/5 | |||
| CD34+/DR+ | 0.1 | 8 × 103 | 0 | ||||
| 5 × 103 | 0 | ||||||
| CD34+/DR− | 0.01 | 3 × 103 | 18 | 5/5 | |||
| CD34+/CD71+/DR+ | 0.06 | NA | |||||
| CD34+/CD71+/DR− | 0.008 | NA | |||||
| CD34+/CD71−/DR+ | 0.04 | 5 × 103 | 0 | ||||
| CD34+/CD71−/DR− | 0.002 | 2272 | 32 | 5/5 | |||
| 400 | 4 | 3/3 | |||||
| CD34− | 99.89 | 106 | 98 | 4/4 | |||
| 105 | 29 | 4/4 | |||||
| 9 | Unsorted | 106 | 0.2 | ||||
| CD34+/DR+ | 4.6 | 7 × 104 | 0 | ||||
| CD34+/DR− | 4.5 | 105 | 0 | ||||
| 8 × 104 | 0 | ||||||
| 7 × 104 | 0 | ||||||
| CD34+/CD71+/DR+ | 3.7 | NA | |||||
| CD34+/CD71+/DR− | 2.9 | NA | |||||
| CD34+/CD71−/DR+ | 0.9 | 8 × 104 | 0 | ||||
| 4 × 104 | 0 | ||||||
| CD34+/CD71−/DR− | 1.6 | 3.7 × 104 | 1 | ||||
| CD34− | 90.9 | ≤106 | 0 | ||||
| 13 | Unsorted | 106 | 0.1 | ||||
| CD34+/DR+ | 10.3 | 5 × 105 | 0 | ||||
| 3.5 × 105 | 0 | ||||||
| CD34+/DR− | 0.07 | 5 × 105 | 4 | 3/3 | |||
| 105 | 0 | ||||||
| CD34+/CD71+/DR+ | 9.6 | NA | |||||
| CD34+/CD71+/DR− | 0.05 | NA | |||||
| CD34+/CD71−/DR+ | 0.7 | 2.5 × 104 | 0 | ||||
| CD34+/CD71−/DR− | 0.02 | 105 | 13 | 3/3 | |||
| 2 × 104 | 3 | 3/3 | |||||
| CD34− | 89.63 | 5 × 106 | 0 | ||||
| 15 | Unsorted | 106 | 36 | ||||
| CD34+/DR+ | 0.11 | 1.7 × 104 | 0 | ||||
| CD34+/DR− | 0.09 | 5.6 × 103 | 29 | ||||
| CD34+/CD71+/DR+ | 0.02 | NA | |||||
| CD34+/CD71+/DR− | 0.01 | NA | |||||
| CD34+/CD71−/DR+ | 0.09 | 5 × 103 | 0 | ||||
| CD34+/CD71−/DR− | 0.08 | 3.7 × 103 | 40 | ||||
| 2.5 × 103 | 19 | ||||||
| CD34− | 99.8 | 106 | 0 | ||||
| 17 | Unsorted | 106 | 13 | ||||
| 5 × 105 | 11 | ||||||
| 105 | 8 | ||||||
| CD34+/DR+ | 1.3 | 2 × 105 | 0 | ||||
| CD34+/DR− | 5.3 | 3 × 105 | 38 | ||||
| CD34− | 93.4 | 106 | 0 | ||||
| 6 × 105 | 0 | ||||||
The remainder of cells to 100% were CD45−.
Abbreviation: NA, data is not available.